Algeta to Participate in Upcoming Investor Conferences

Algeta to Participate in Upcoming Investor Conferences 
OSLO, NORWAY -- (Marketwire) -- 02/20/13 --  Algeta ASA (OSE:
ALGETA), a company focused on the development of novel targeted
cancer therapeutics, announces that members of its senior management
team will participate in the following upcoming investor
Citi Global Healthcare Conference 2013 
Date: 25-27 February 2013 
Jeff Albers (President, Algeta US) 
Mike Booth (IR) 
Panel date & time: Tuesday 25 February, 2013, 10:20am EST 
Venue: New York, NY, USA 
Credit Suisse Global Healthcare
One-on-One Conference 
Date: 5-6 March 2013 
Andrew Kay (President & CEO) 
Oystein Soug (CFO) 
Mike Booth (IR) 
Venue: London, UK 
Carnegie Nordic Healthcare Seminar 
Date: 12 March 2013 
Thomas Ramdahl (EVP & CTO) 
Renate Birkeli (IR) 
Presentation date & time: Tuesday 12 March, 2013, 10:05am CET 
Venue: Stockholm, Sweden 
Presentations, where applicable, will be available to download at
following these events. 
About Algeta 
Algeta is a company focused on developing novel targeted therapies
for patients
with cancer based on its alpha-pharmaceutical platform.
The Company is headquartered in Oslo, Norway, and has a US
subsidiary, Algeta US, LLC, based in Cambridge, MA performing
commercial marketing operations in the US. Algeta is
listed on the
Oslo Stock Exchange (Ticker: ALGETA). For more information
Press release: 
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants
(i) the releases contained herein are protected by copyright and    
other applicable laws; and 
(ii) they are solely responsible for the content, accuracy and     
originality of the information contained therein. 
Source: Algeta ASA via Thomson Reuters ONE 
For further information, please contact: 
Mike Booth / Renate Birkeli
+47 23 00 67 32
Communications & Corporate Affairs 
Media enquiries:
Mark Swallow
+44 207 638 9571 
Citigate Dewe Rogerson 
Knut Ekern
+47 22 04 82 00 
Gambit Hill & Knowlton 
Kari Watson
+1 781 235 3060 
MacDougall Biomedical Communications 
US investor enquiries:
Tricia Swanson
+1 646 378 2953 
The Trout Group
Press spacebar to pause and continue. Press esc to stop.